se ha leído el artículo
array:24 [ "pii" => "S157821901200306X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.07.020" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "696" "copyright" => "Elsevier España, S.L. and AEDV" "copyrightAnyo" => "2012" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:880-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4319 "formatos" => array:3 [ "EPUB" => 48 "HTML" => 3530 "PDF" => 741 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731012003523" "issn" => "00017310" "doi" => "10.1016/j.ad.2012.07.006" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "696" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:880-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4054 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 3174 "PDF" => 878 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Novedades en Dermatología</span>" "titulo" => "Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "880" "paginaFinal" => "886" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Interferon γ Assays in the Diagnosis of Tuberculosis Infection in Psoriasis Patients Who Are Candidates for Biologic Therapies" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2097 "Ancho" => 2993 "Tamanyo" => 291804 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La técnica T-SPOT<span class="elsevierStyleSup">®</span>.TB requiere una separación previa de células mononucleares de sangre periférica (PBMC, por sus siglas en inglés) para su estimulación y determina la presencia de IFN-γ mediante ELISPOT. Los antígenos específicos de <span class="elsevierStyleItalic">M. tuberculosis</span>, ESAT-6 y CFP-10, se emplean por separado para la estimulación de las PBMC. La presencia de células T reactivas se observa mediante la aparición de <span class="elsevierStyleItalic">spots</span> en el pocillo, que se cuentan de forma manual y/o con un lector automático de placas. Se considera que un resultado es positivo si la muestra presenta más de 6 <span class="elsevierStyleItalic">spots</span> para ESAT-6 o CFP-10 que en el control negativo, y este número es el doble que el del control negativo. El resultado de la técnica se considera indeterminado si el número de <span class="elsevierStyleItalic">spots</span> en el control positivo es menor que 20, y la respuesta a los antígenos específicos es negativa.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Domínguez, M. Vilavella, I. Latorre" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Domínguez" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "Vilavella" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Latorre" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S157821901200306X" "doi" => "10.1016/j.adengl.2012.07.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901200306X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012003523?idApp=UINPBA000044" "url" => "/00017310/0000010300000010/v1_201304241557/S0001731012003523/v1_201304241557/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219012003071" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.04.016" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "629" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2012;103:887-96" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3470 "formatos" => array:3 [ "EPUB" => 47 "HTML" => 2809 "PDF" => 614 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Biosynthetic Porcine Collagen Dressings as an Adjunct or Definitive Tool for the Closure of Scalp Defects Without Periosteum" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "887" "paginaFinal" => "896" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Parche biosintético de colágeno porcino como herramienta coadyuvante o definitiva en el cierre de defectos del cuero cabelludo sin periostio" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2035 "Ancho" => 2521 "Tamanyo" => 332337 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Epidemiological characteristics of the patients included in the study.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Martorell-Calatayud, V. Sanz-Motilva, E. Nagore, C. Serra-Guillén, O. Sanmartín, B. Echeverría, C. Guillén- Barona" "autores" => array:7 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Martorell-Calatayud" ] 1 => array:2 [ "nombre" => "V." "apellidos" => "Sanz-Motilva" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Nagore" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Serra-Guillén" ] 4 => array:2 [ "nombre" => "O." "apellidos" => "Sanmartín" ] 5 => array:2 [ "nombre" => "B." "apellidos" => "Echeverría" ] 6 => array:2 [ "nombre" => "C. Guillén-" "apellidos" => "Barona" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S000173101200213X" "doi" => "10.1016/j.ad.2012.04.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101200213X?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003071?idApp=UINPBA000044" "url" => "/15782190/0000010300000010/v1_201304241352/S1578219012003071/v1_201304241352/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219012003058" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.01.022" "estado" => "S300" "fechaPublicacion" => "2012-12-01" "aid" => "604" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:874-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4819 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 3748 "PDF" => 1022 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Allergic Contact Dermatitis to Fragrances. Part 1" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "874" "paginaFinal" => "879" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatitis de contacto alérgica por fragancias. Parte I" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2162 "Ancho" => 1583 "Tamanyo" => 253901 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Contact dermatitis due to fragrances manifesting as axillary eczema associated with the use of a deodorant containing lyral. A, Erythematous lesions with an eczematous appearance that had appeared on the right axilla several weeks previously. B, Patch test with lyral showing a positive reading at 72<span class="elsevierStyleHsp" style=""></span>hours.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.P. Arribas, P. Soro, J.F. Silvestre" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M.P." "apellidos" => "Arribas" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Soro" ] 2 => array:2 [ "nombre" => "J.F." "apellidos" => "Silvestre" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731012001615" "doi" => "10.1016/j.ad.2012.01.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012001615?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012003058?idApp=UINPBA000044" "url" => "/15782190/0000010300000010/v1_201304241352/S1578219012003058/v1_201304241352/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Novelties in dermatology</span>" "titulo" => "Interferon γ Assays in the Diagnosis of Tuberculosis Infection in Psoriasis Patients Who Are Candidates for Biologic Therapies" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "880" "paginaFinal" => "886" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J. Domínguez, M. Vilavella, I. Latorre" "autores" => array:3 [ 0 => array:4 [ "nombre" => "J." "apellidos" => "Domínguez" "email" => array:1 [ 0 => "jadomb@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "M." "apellidos" => "Vilavella" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "I." "apellidos" => "Latorre" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Microbiología, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "CIBER Enfermedades Respiratorias" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2097 "Ancho" => 2993 "Tamanyo" => 279198 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The T-SPOT.<span class="elsevierStyleItalic">TB</span> technique uses isolated peripheral blood mononuclear cells to detect interferon γ released by stimulated T cells using the enzyme-linked immunospot assay. The cells are stimulated by the <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span>-specific antigens ESAT-6 and CFP-10, applied separately. The appearance of spots in the well indicates the presence of reactive T cells. These spots are then counted manually or with an automated plate reader. The result is interpreted as positive if there are at least 6 more spots in either or both of the ESAT-6 or CFP-10 panels than in the nil control panel; the spot count in the antigen panels must also be twice that of the nil control panel. The result is considered indeterminate if there are fewer than 20 spots in the positive control panel and fewer than 6 spots in the antigen panels.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Psoriasis is a chronic inflammatory disease that affects a considerable proportion of the population. It can be severe and is an important cause of occupational disability in middle-aged patients, resulting in considerable personal and socioeconomic impacts. Biologic therapy, particularly that involving anti-tumor necrosis factor (TNF) α agents, has emerged as a viable alternative for the treatment of psoriasis in cases when conventional systemic agents are either ineffective or contraindicated.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The use of biologic therapy, however, requires prior evaluation and monitoring of patients, as serious bacterial infections have been reported in association with anti-TNF-α therapy. Particular consideration should be given to the risk of tuberculosis (TB), as a clear link has been established between anti-TNF-α therapy and reactivation of latent TB infection.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> The main route of TB infection is respiratory. <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span> is inhaled into the pulmonary alveoli, where it is phagocytosed by alveolar macrophages. <span class="elsevierStyleItalic">M tuberculosis</span> is an intracellular pathogen; it avoids destruction by preventing the fusion of phagosomes with lysosomes and it replicates within the macrophage, which is eventually completely destroyed. The infected macrophage releases cytokines that attract neutrophils, lymphocytes, and more macrophages, creating a focus of inflammation. Type 1 helper (T<span class="elsevierStyleInf">H</span>1) cells are responsible for mounting the immune response, as they secrete both TNF-α, which attracts more macrophages, and interferon (IFN) γ, which activates infected macrophages. TNF-α plays a key role in forming and maintaining the tuberculous granuloma and hence in containing infection. It is essential to rule out latent TB infection and, of course, active TB, in all patients due to start anti-TNF-α therapy.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Diagnosis of TB Infection</span><p id="par0015" class="elsevierStylePara elsevierViewall">The tuberculin skin test (TST) has been used for over 100 years to diagnose TB infection. Tuberculin is obtained by concentration of the sterilized filtrate of a culture of <span class="elsevierStyleItalic">M tuberculosis</span>. The test is currently conducted with tuberculin purified protein derivative (PPD), which is a mixture of over 200<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">M tuberculosis</span> proteins. In Spain, the recommendation is to use tuberculin PPD RT23 with Tween 80 (Statens Serum Institut). The standard dose is 2 tuberculin units per 0.1 mL, which is bioequivalent to the recommended 5-unit dose of the international standard tuberculin, PPD-S.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The TST is performed using the Mantoux technique, which consists of injecting 0.1<span class="elsevierStyleHsp" style=""></span>mL of solution containing the corresponding tuberculin dose into the anterior surface of the forearm, with reading of results at 48 to 72<span class="elsevierStyleHsp" style=""></span>hours. Sensitized individuals develop a delayed hypersensitivity reaction, which produces an induration at the site of injection. This immune response is mediated by T<span class="elsevierStyleInf">H</span>1 cells that migrate to the site of injection and trigger the release of several cytokines on recognizing the antigens presented by major histocompatibility complex class II molecules. The cytokines then activate the macrophages, causing a reaction characterized by erythema and induration.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In order to reduce the risk of developing TB during treatment with biologic agents, current guidelines recommend that all information indicating past TB infection or recent contact with individuals with TB should be included in patients’ medical records. Other recommendations include the performance of a TST and a chest radiograph to check for signs of past infection or active disease. If the TST is positive (induration of ≥<span class="elsevierStyleHsp" style=""></span>5<span class="elsevierStyleHsp" style=""></span>mm at 72<span class="elsevierStyleHsp" style=""></span>hours), the individual is considered to be infected. If an induration of less than 5<span class="elsevierStyleHsp" style=""></span>mm is observed, a second test is performed 2 weeks later (to avoid the booster effect), and the result is considered positive for tuberculosis if the induration is 5<span class="elsevierStyleHsp" style=""></span>mm or larger.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The main disadvantage of the TST is that most of the proteins in the PPD are not specific to <span class="elsevierStyleItalic">M tuberculosis.</span> This reduces the specificity of the test, as individuals who have been exposed to nontuberculous mycobacteria (NTM) or who have received the <span class="elsevierStyleItalic">Mycobacterium bovis</span> BCG vaccine develop an immune response to PPD. Furthermore, the TST also has low sensitivity in patients with altered cell-mediated immunity, who are precisely the patients who need this test most due to their higher risk of developing active TB if infected. This reduced sensitivity is of particular relevance in patients with psoriasis who are candidates for biologic therapy as they will have been treated with immunosuppressives and may therefore have an altered immune response.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">In Vitro Techniques Based on IFN-γ Release</span><p id="par0035" class="elsevierStylePara elsevierViewall">Immunodiagnostic tests based on the in vitro quantification of the cellular immune response may provide an alternative for diagnosing TB infection. In recent years, a range of techniques have been developed to quantify this response using different mycobacterial antigens to stimulate sensitized T cells and detect the release of IFN-γ in vitro. In infected individuals, sensitized T cells release easily detectable quantities of IFN-γ when stimulated with <span class="elsevierStyleItalic">M tuberculosis</span>–specific antigens. The technology underlying these diagnostic methods is based on the principles of the enzyme-linked immunosorbent assay (ELISA) and the enzyme-linked immunospot (ELISPOT) assay, which, respectively, have given rise to 2 commercial IFN-γ release assays (IGRAs): QuantiFERON-TB Gold In-Tube test (QFT) (Cellestis) and T-SPOT.<span class="elsevierStyleItalic">TB</span> (Oxford Immunotec). Both tests have US Food and Drug Administration approval and use immunoassay technology to detect IFN-γ released by T cells stimulated with <span class="elsevierStyleItalic">M tuberculosis</span>–specific antigens. The success of the techniques depends on, among other factors, the antigens used. The use of region of difference (RD) 1 antigens, such as ESAT-6 and CFP-10, which are secreted by <span class="elsevierStyleItalic">M tuberculosis</span> complex and are not present in the BCG vaccine or NTM species, appears to be an extremely effective means of detecting TB infection.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In QFT, IFN-γ release is measured by ELISA in whole blood samples, while in T-SPOT.<span class="elsevierStyleItalic">TB</span>, it is measured by ELISPOT in previously isolated peripheral blood mononuclear cells (PBMCs). One of the main differences between these 2 in vitro techniques is that in QFT, a single mixture of <span class="elsevierStyleItalic">M tuberculosis</span>–specific antigens (ESAT-6, CFP-10, and TB7.7) is used to stimulate whole blood, while in T-SPOT-<span class="elsevierStyleItalic">TB</span>, 2 separate mixtures (ESAT-6 and CFP-10) are used to stimulate PBMCs. The third antigen in QFT, TB7.7 (Rv2654), is an RD11-encoded antigen absent from the BCG vaccine and NTM species. <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> summarizes the main characteristics of QFT, T-SPOT.<span class="elsevierStyleItalic">TB</span>, and the TST.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Clinical Performance of IGRAs</span><p id="par0045" class="elsevierStylePara elsevierViewall">IGRAs have been reported to be more specific than the TST in BCG-vaccinated patients and also to correlate better with the degree of exposure to <span class="elsevierStyleItalic">M tuberculosis</span>.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6–10</span></a> Recent studies have shown that these assays have predictive value for the development of active TB,<a class="elsevierStyleCrossRefs" href="#bib0055"><span class="elsevierStyleSup">11–14</span></a> and there is increasing evidence that they are robust tools for diagnosing TB infection in individuals with a deficient cellular immune response,<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,16</span></a> as can occur in children,<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,17,18</span></a> patients coinfected with human immunodeficiency virus,<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19–23</span></a> and immunosuppressed patients.<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">24–26</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">IGRAs can detect the absence of an immune response as they have internal controls to detect anergy. Accordingly, a negative mitogen (positive control) result and a negative antigen result must be interpreted as an indeterminate result, indicating the presence of an impaired T-cell response. A negative TST result in a patient with an indeterminate IGRA result could be a false negative TST. Indeterminate results have been associated with young age (< 5 years), immunosuppression, and negative TST results.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,27,28</span></a><a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a> shows the range of results that can be obtained using the T-SPOT.<span class="elsevierStyleItalic">TB</span> test.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Performance of IGRAs in Psoriasis Patients Due to Receive Biologic Therapy</span><p id="par0055" class="elsevierStylePara elsevierViewall">Several studies have assessed the value of IGRAs in the diagnosis of <span class="elsevierStyleItalic">M tuberculosis</span> infection in patients with a chronic inflammatory disease being considered for biologic therapy.<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26,29–36</span></a> The populations analyzed, however, were quite heterogeneous (mixture of patients with rheumatoid disease, digestive disorders, and dermatologic conditions) and had different degrees of drug-induced immunosuppression. Furthermore, some of the patients had already been treated with anti-TNF-α agents and several of the studies used earlier versions of QFT. These differences make it difficult to accurately assess the utility of IGRAs for the diagnosis of TB infection in psoriasis patients scheduled for biologic therapy.</p><p id="par0060" class="elsevierStylePara elsevierViewall">A number of recent studies have analyzed the value of IGRAs in psoriasis,<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">37–40</span></a>with results confirming that these assays are less influenced by the BCG vaccine than the TST.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> In one of these studies, De Andrade Lima et al.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a> reported a much higher frequency of positive TST results and induration size in controls (patients with common dermatologic disorders not including psoriasis) than in patients with untreated moderate to severe psoriasis. The authors, however, found no significant differences between the groups in terms of the frequency of positive T-SPOT.<span class="elsevierStyleItalic">TB</span> results or the number of spots elicited by the test. They concluded that the T-SPOT.<span class="elsevierStyleItalic">TB</span> test performed better than the TST in diagnosing latent TB infection in patients with psoriasis and suggested that this was because the in vitro test was less influenced by the immune dysregulation that characterizes psoriasis.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Value of IGRAs in Predicting Disease Progression</span><p id="par0065" class="elsevierStylePara elsevierViewall">If IGRAs are to be incorporated into routine clinical practice, it is crucial to establish the safety of not prescribing TB prophylactic treatment in patients with a positive TST and a negative IGRA result (regardless of BCG-vaccination status) due to start immunosuppressive therapy. Very little is known about screening for TB infection during anti-TNF-α therapy or about the value of IGRAs in predicting disease progression. At the present time, it would therefore seem wise to use both the TST and an IGRA in such cases and to consider a diagnosis of TB infection when a positive result is observed with either of the tests. Nevertheless, there are preliminary results suggesting that IGRAs might be used as a stand-alone tool in the not so distant future.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">37,38,40</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">Laffitte et al.,<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">38</span></a> for example, used the TST and T-SPOT.<span class="elsevierStyleItalic">TB</span> to test 50 patients with psoriasis before they were due to start anti-TNF-α therapy. Twenty-eight patients had a negative result on both tests, 12 had a positive TST result and a negative T-SPOT.<span class="elsevierStyleItalic">TB</span> result, and 10 patients had a positive T-SPOT.<span class="elsevierStyleItalic">TB</span> result (8 of these also had a positive TST). Thirty-eight patients with a negative T-SPOT.<span class="elsevierStyleItalic">TB</span> result did not receive prophylactic treatment and none developed TB in 4 years of follow-up. Garcovich et al.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">37</span></a> also screened for TB infection with the TST and QFT in 50 patients about to start anti-TNF-α therapy. None of the patients with a negative QFT result and a normal chest radiograph received prophylactic treatment, and none of them developed TB in a follow-up period of 18 months. The authors also performed screening tests during the first 12 months of biologic therapy and observed 5 QFT conversions (3 at 6 months and 2 at 12 months). TB prophylaxis was prescribed in 4 of these patients, none of whom had developed active TB at follow-up. Finally, Chiu et al.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">40</span></a> used QFT to screen for latent TB infection in 100 patients with psoriasis receiving biologic therapy and observed 12 positive results. For different reasons, prophylactic treatment was prescribed in just 4 of these patients. Of the 100 patients analyzed, only 1—a patient with a positive QFT result who refused prophylaxis—developed active TB.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Indeterminate and Discordant Results</span><p id="par0075" class="elsevierStylePara elsevierViewall">Little is known about the effect of immunosuppressive drugs on IGRA results, although Soborg et al.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a> showed that corticosteroid treatment was associated with an increased risk of an indeterminate QFT result and a lower frequency of positive TST results. In our experience, patients with psoriasis have a higher rate of positive T-SPOT.<span class="elsevierStyleItalic">TB</span> and QFT results and a lower rate of indeterminate results than patients with Crohn disease.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">41</span></a> The differences are probably due to the different immunosuppresive agents that patients had received before starting anti-TNF-α therapy.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Most studies attribute discordant results between IGRAs and the TST to the BCG vaccine, but positive TST and negative IGRA results have also been observed in patients who have not been vaccinated. One possible explanation for this discordance is sensitization to NTM. In fact, our group has shown that NTM exposure might explain discordant results between IGRAs and the TST.<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">17,42</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Future Developments</span><p id="par0085" class="elsevierStylePara elsevierViewall">One of the challenges facing IGRA testing is to improve sensitivity without loss of specificity and to reduce the number of indeterminate results. Recent studies analyzing new biomarkers for the diagnosis of latent TB infection and active TB could open the door to the use of new antigens<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">43,44</span></a> and testing for multiple cytokines in future generations of IGRAs.<a class="elsevierStyleCrossRefs" href="#bib0225"><span class="elsevierStyleSup">45–47</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conclusions</span><p id="par0090" class="elsevierStylePara elsevierViewall">In brief, IGRAs are a promising alternative to the TST for the diagnosis of TB infection. They are not affected by the BCG vaccine or sensitization to NTM and therefore have higher specificity and sensitivity. Furthermore, they are less influenced by prior treatment with immunosuppressive agents. However, because safety must be a top priority, we recommend that patients currently being considered for anti-TNF-α therapy should be tested with both an IGRA and the TST. Nevertheless, given that both in vitro tests have high negative predicitive value, in the not so distant future, it is foreseeable that IGRAs will be used as a stand-alone test. Further studies are needed to improve our understanding of these in vitro techniques and to help in the design of individualized follow-up strategies.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Ethical Disclosures</span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Protection of Human and Animal Subjects</span><p id="par0095" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this investigation.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Confidentiality of Data</span><p id="par0100" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Right to Privacy and Informed Consent</span><p id="par0105" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article.</p></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Funding</span><p id="par0110" class="elsevierStylePara elsevierViewall">This article was funded by the Spanish Health Research Fund (FIS, PI 10/00214). J Domínguez is a researcher funded by the Miguel Servet program of the Instituto de Salud Carlos III (Spain).</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflicts of Interest</span><p id="par0115" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:17 [ 0 => array:2 [ "identificador" => "xres96495" "titulo" => "Abstract" ] 1 => array:2 [ "identificador" => "xpalclavsec83654" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres96494" "titulo" => "Resumen" ] 3 => array:2 [ "identificador" => "xpalclavsec83655" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Diagnosis of TB Infection" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "In Vitro Techniques Based on IFN-γ Release" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Clinical Performance of IGRAs" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Performance of IGRAs in Psoriasis Patients Due to Receive Biologic Therapy" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Value of IGRAs in Predicting Disease Progression" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Indeterminate and Discordant Results" ] 11 => array:2 [ "identificador" => "sec0040" "titulo" => "Future Developments" ] 12 => array:2 [ "identificador" => "sec0045" "titulo" => "Conclusions" ] 13 => array:3 [ "identificador" => "sec0050" "titulo" => "Ethical Disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0055" "titulo" => "Protection of Human and Animal Subjects" ] 1 => array:2 [ "identificador" => "sec0060" "titulo" => "Confidentiality of Data" ] 2 => array:2 [ "identificador" => "sec0065" "titulo" => "Right to Privacy and Informed Consent" ] ] ] 14 => array:2 [ "identificador" => "sec0070" "titulo" => "Funding" ] 15 => array:2 [ "identificador" => "sec0075" "titulo" => "Conflicts of Interest" ] 16 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2012-04-14" "fechaAceptado" => "2012-07-20" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec83654" "palabras" => array:5 [ 0 => "Tuberculosis" 1 => "Psoriasis" 2 => "In vitro IFN-γ assay" 3 => "Tuberculin" 4 => "Anti-TNF-α treatment" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec83655" "palabras" => array:5 [ 0 => "Tuberculosis" 1 => "Psoriasis" 2 => "Técnicas in vitro del IFN-γ" 3 => "Tuberculina" 4 => "Tratamiento anti-TNF-α" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Although there is no doubt that biologic agents are an effective alternative for the treatment of moderate and severe psoriasis, anti-tumor necrosis factor <span class="elsevierStyleBold">α</span> therapy has been associated with reactivation of latent tuberculosis infection. Tuberculin skin testing (TST) is used to diagnose tuberculosis infection but it has low specificity in patients who have received the <span class="elsevierStyleItalic">Mycobacterium bovis</span> BCG vaccine and low sensitivity in patients with altered cell-mediated immunity. In vitro assays based on the detection of interferon γ released by T cells stimulated by specific <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span> antigens have emerged as an option for the diagnosis of tuberculosis infection. The results to date show that they are a viable alternative to TST thanks to their higher specificity and sensitivity. Furthermore, these assays are also proving to have high negative predictive value, meaning that we might be able to use them without TST in the short to medium term.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Las terapias biológicas representan una alternativa de indudable eficacia en la psoriasis moderada y grave. Sin embargo, existe una asociación entre el tratamiento con anti-TNF-α y la reactivación de la infección tuberculosa. La tuberculina se utiliza como herramienta para el diagnóstico de la infección tuberculosa, pero presenta una baja especificidad en pacientes vacunados con la BCG (<span class="elsevierStyleItalic">Mycobacterium bovis</span> bacilo de Calmette-Guérin) y una baja sensibilidad en pacientes con alteraciones de la inmunidad celular. En este sentido se han desarrollado diferentes metodologías in vitro que incorporan antígenos específicos de <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span> para estimular células T sensibilizadas y detectar posteriormente IFN-γ liberado para el diagnóstico in vitro de la infección tuberculosa. Los resultados obtenidos hasta ahora muestran a estas como una alternativa real a la tuberculina, ya que presentan una mayor especificidad y sensibilidad. Estas técnicas, además, están demostrando un elevado valor predictivo negativo que hace que nos podamos plantear a corto-medio plazo su utilización sin necesidad de combinarla con la tuberculina.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara">Please cite this article as: Domínguez J, et al. Técnicas basadas en la detección de IFN-γ en el diagnóstico de la infección tuberculosa en pacientes con psoriasis candidatos a terapias biológicas. Actas Dermosifiliogr. 2012;103:880–6.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2097 "Ancho" => 2993 "Tamanyo" => 279198 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The T-SPOT.<span class="elsevierStyleItalic">TB</span> technique uses isolated peripheral blood mononuclear cells to detect interferon γ released by stimulated T cells using the enzyme-linked immunospot assay. The cells are stimulated by the <span class="elsevierStyleItalic">Mycobacterium tuberculosis</span>-specific antigens ESAT-6 and CFP-10, applied separately. The appearance of spots in the well indicates the presence of reactive T cells. These spots are then counted manually or with an automated plate reader. The result is interpreted as positive if there are at least 6 more spots in either or both of the ESAT-6 or CFP-10 panels than in the nil control panel; the spot count in the antigen panels must also be twice that of the nil control panel. The result is considered indeterminate if there are fewer than 20 spots in the positive control panel and fewer than 6 spots in the antigen panels.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: ELISA, enzyme-linked immunosorbent assay; ELISPOT, enzyme-linked immunospot assay; IFN, interferon; NTM, nontuberculous mycobacteria; PBMC, peripheral blood mononuclear cells; PPD, purified protein derivative.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">T-SPOT<span class="elsevierStyleSup">®</span>.<span class="elsevierStyleItalic">TB</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">QFT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">TST \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Type of test \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">In vitro \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">In vitro \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">In vivo \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Biologic sample \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PBMCs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Whole blood \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Not applicable (in vivo test by intradermal injection) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Antigens \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Separate solutions of ESAT-6 and CFP-10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Single mixture of ESAT-6, CFP-10, and TB7.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">PPD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Measurement system \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">ELISPOT \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">ELISA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Induration size \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Measurement units \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No. of effector cells that secrete IFN-γ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">International units of released IFN-γ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Possible results \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive, negative, or indeterminate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive, negative, or indeterminate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Positive or negative \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Time \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18-24 h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18-24 h \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">48-72<span class="elsevierStyleHsp" style=""></span>h \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Laboratory equipment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cross-reaction with BCG vaccine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cross-reaction with NTM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Internal anergy control \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Booster effect \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Second patient visit \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Yes \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab182534.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Characteristics of the T-SPOT.<span class="elsevierStyleItalic">TB</span> Assay, the QuantiFERON-TB Gold In-Tube (QFT) Assay, and the Tuberculin Skin Test (TST).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:47 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumor necrosis factor biologics beyond psoriasis in dermatology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Patel" 1 => "J.M. Cafardi" 2 => "N. Patel" 3 => "N. Sami" 4 => "J.A. Cafardi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/14712598.2011.590798" "Revista" => array:6 [ "tituloSerie" => "Expert Opin Biol Ther" "fecha" => "2011" "volumen" => "11" "paginaInicial" => "1341" "paginaFinal" => "1359" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21651458" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.A. Gardam" 1 => "E.C. Keystone" 2 => "R. Menzies" 3 => "S. Manners" 4 => "E. Skamene" 5 => "R. Long" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet Infect Dis" "fecha" => "2003" "volumen" => "3" "paginaInicial" => "148" "paginaFinal" => "155" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12614731" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Keane" 1 => "S. Gershon" 2 => "R.P. Wise" 3 => "E. Mirabile-Levens" 4 => "J. Kasznica" 5 => "W.D. Schwieterman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa011110" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2001" "volumen" => "345" "paginaInicial" => "1098" "paginaFinal" => "1104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11596589" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Carmona" 1 => "J.J. Gómez-Reino" 2 => "V. Rodríguez-Valverde" 3 => "D. Montero" 4 => "E. Pascual-Gómez" 5 => "E.M. Mola" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.21043" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2005" "volumen" => "52" "paginaInicial" => "1766" "paginaFinal" => "1772" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15934089" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SEPAR Guidelines. Diagnostic and treatment of tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Ruiz-Manzano" 1 => "R. Blanquer" 2 => "J.L. Calpe" 3 => "J.A. Caminero" 4 => "J. Caylà" 5 => "J. Domínguez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2008" "volumen" => "44" "paginaInicial" => "551" "paginaFinal" => "566" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19006636" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S000293940800771X" "estado" => "S300" "issn" => "00029394" ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of two interferon-gamma assays and tuberculin skin test for tracing TB contacts" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.M. Arend" 1 => "S.F. Thijsen" 2 => "E.M. Leyten" 3 => "J.J. Bouwman" 4 => "W.P. Franken" 5 => "B.F. Koster" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200608-1099OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2007" "volumen" => "175" "paginaInicial" => "618" "paginaFinal" => "627" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17170386" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Ewer" 1 => "J. Deeks" 2 => "L. Álvarez" 3 => "G. Bryant" 4 => "S. Waller" 5 => "P. Andersen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(03)12950-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2003" "volumen" => "361" "paginaInicial" => "1168" "paginaFinal" => "1173" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12686038" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ferrara" 1 => "M. Losi" 2 => "R. D’Amico" 3 => "P. Roversi" 4 => "R. Piro" 5 => "M. Meacci" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(06)68579-6" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2006" "volumen" => "367" "paginaInicial" => "1328" "paginaFinal" => "1334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16631911" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Lalvani" 1 => "P. Nagvenkar" 2 => "Z. Udwadia" 3 => "A.A. Pathan" 4 => "K.A. Wilkinson" 5 => "J.S. Shastri" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/318081" "Revista" => array:6 [ "tituloSerie" => "J Infect Dis" "fecha" => "2001" "volumen" => "183" "paginaInicial" => "469" "paginaFinal" => "477" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11133379" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Porsa" 1 => "L. Cheng" 2 => "E.A. Graviss" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CVI.00073-07" "Revista" => array:6 [ "tituloSerie" => "Clin Vaccine Immunol" "fecha" => "2007" "volumen" => "14" "paginaInicial" => "714" "paginaFinal" => "719" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17442844" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Bakir" 1 => "K.A. Millington" 2 => "A. Soysal" 3 => "J.J. Deeks" 4 => "S. Efee" 5 => "Y. Aslan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2008" "volumen" => "149" "paginaInicial" => "777" "paginaFinal" => "787" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18936496" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictive value of a whole-blood IFN-gamma assay for the development of active TB disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Diel" 1 => "R. Loddenkemper" 2 => "K. Meywald-Walter" 3 => "S. Niemann" 4 => "A. Nienhaus" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200711-1613OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2008" "volumen" => "177" "paginaInicial" => "1164" "paginaFinal" => "1170" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18276940" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Negative and positive predictive value of a whole-blood IGRA for developing active TB. An update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Diel" 1 => "R. Loddenkemper" 2 => "S. Niemann" 3 => "K. Meywald-Walter" 4 => "A. Nienhaus" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201006-0974OC" "Revista" => array:7 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2011" "volumen" => "183" "paginaInicial" => "88" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20802162" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002939410002631" "estado" => "S300" "issn" => "00029394" ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P.C. Hill" 1 => "D. Jackson-Sillah" 2 => "A. Fox" 3 => "R.H. Brookes" 4 => "B.C. De Jong" 5 => "M.D. Lugos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "PLoS ONE" "fecha" => "2008" "volumen" => "3" "paginaInicial" => "1379" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Domínguez" 1 => "I. Latorre" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMe1415053" "Revista" => array:6 [ "tituloSerie" => "J Crohn's & Colitis" "fecha" => "2008" "volumen" => "2" "paginaInicial" => "250" "paginaFinal" => "254" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25785975" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IFN-gamma-release assays to diagnose TB infection in the immunocompromised individual" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Domínguez" 1 => "I. Latorre" 2 => "N. Altet" 3 => "L. Mateo" 4 => "M. De Souza-Galvao" 5 => "J. Ruiz-Manzano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/ers.09.20" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Respir Med" "fecha" => "2009" "volumen" => "3" "paginaInicial" => "309" "paginaFinal" => "327" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20477323" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosing TB infection in children: analysis of discordances using in vitro tests and tuberculin skin test" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Altet" 1 => "M. De Souza-Galvao" 2 => "I. Latorre" 3 => "C. Milà" 4 => "M.A. Jiménez" 5 => "J. Solsona" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00022710" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2011" "volumen" => "37" "paginaInicial" => "1166" "paginaFinal" => "1174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20729220" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "T cell-based diagnosis of childhood tuberculosis infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Lalvani" 1 => "K.A. Millington" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/QCO.0b013e32813e3fd8" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Infect Dis" "fecha" => "2007" "volumen" => "20" "paginaInicial" => "264" "paginaFinal" => "271" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17471036" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.L. Chapman" 1 => "M. Munkanta" 2 => "K.A. Wilkinson" 3 => "A.A. Pathan" 4 => "K. Ewer" 5 => "H. Ayles" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2002" "volumen" => "16" "paginaInicial" => "2285" "paginaFinal" => "2293" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12441800" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Dheda" 1 => "A. Lalvani" 2 => "R.F. Miller" 3 => "G. Scott" 4 => "H. Booth" 5 => "M.A. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "AIDS" "fecha" => "2005" "volumen" => "19" "paginaInicial" => "2038" "paginaFinal" => "2041" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16260914" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IFN-gamma response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Latorre" 1 => "X. Martínez-Lacasa" 2 => "R. Font" 3 => "A. Lacoma" 4 => "J. Puig" 5 => "C. Tural" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2334-10-348" "Revista" => array:5 [ "tituloSerie" => "BMC Infect Dis" "fecha" => "2010" "volumen" => "10" "paginaInicial" => "348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21143955" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of tests for latent tuberculosis in different groups of immunocompromised patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Richeldi" 1 => "M. Losi" 2 => "R. D’Amico" 3 => "M. Luppi" 4 => "A. Ferrari" 5 => "C. Mussini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.08-2575" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2009" "volumen" => "136" "paginaInicial" => "198" "paginaFinal" => "204" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19318676" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Leidl" 1 => "H. Mayanja-Kizza" 2 => "G. Sotgiu" 3 => "J. Baseke" 4 => "M. Ernst" 5 => "C. Hirsch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00045509" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2009" "volumen" => "35" "paginaInicial" => "619" "paginaFinal" => "626" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19608590" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Cobanoglu" 1 => "U. Ozcelik" 2 => "U. Kalyoncu" 3 => "S. Ozen" 4 => "S. Kiraz" 5 => "N. Gurcan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Tuberc Lung Dis" "fecha" => "2007" "volumen" => "11" "paginaInicial" => "1177" "paginaFinal" => "1182" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17958978" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early diagnosis of subclinical multidrug-resistant tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Richeldi" 1 => "K. Ewer" 2 => "M. Losi" 3 => "D.M. Hansell" 4 => "P. Roversi" 5 => "L.M. Fabbri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2004" "volumen" => "140" "paginaInicial" => "709" "paginaFinal" => "713" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15126254" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Mínguez" 1 => "I. Latorre" 2 => "L. Mateo" 3 => "A. Lacoma" 4 => "J. Díaz" 5 => "A. Olive" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-012-1938-z" "Revista" => array:6 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2012" "volumen" => "31" "paginaInicial" => "785" "paginaFinal" => "794" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22271230" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Haustein" 1 => "D.A. Ridout" 2 => "J.C. Hartley" 3 => "U. Thaker" 4 => "D. Shingadia" 5 => "N.J. Klein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/INF.0b013e3181a16394" "Revista" => array:6 [ "tituloSerie" => "Pediatr Infect Dis J" "fecha" => "2009" "volumen" => "28" "paginaInicial" => "669" "paginaFinal" => "673" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19633512" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Liebeschuetz" 1 => "S. Bamber" 2 => "K. Ewer" 3 => "J. Deeks" 4 => "A.A. Pathan" 5 => "A. Lalvani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(04)17592-2" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2004" "volumen" => "364" "paginaInicial" => "2196" "paginaFinal" => "2203" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15610806" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Vassilopoulos" 1 => "N. Stamoulis" 2 => "E. Hadziyannis" 3 => "A.J. Archimandritis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2008" "volumen" => "35" "paginaInicial" => "1271" "paginaFinal" => "1276" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18381793" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Soborg" 1 => "M. Ruhwald" 2 => "M.L. Hetland" 3 => "S. Jacobsen" 4 => "A.B. Andersen" 5 => "N. Milman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3899/jrheum.081292" "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "2009" "volumen" => "36" "paginaInicial" => "1876" "paginaFinal" => "1884" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19648300" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Bélard" 1 => "S. Semb" 2 => "M. Ruhwald" 3 => "A.M. Werlinrud" 4 => "B. Soborg" 5 => "F.K. Jensen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ibd.21605" "Revista" => array:7 [ "tituloSerie" => "Inflamm Bowel Dis" "fecha" => "2011" "volumen" => "17" "paginaInicial" => "2340" "paginaFinal" => "2349" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21319275" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S001078249900089X" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Bocchino" 1 => "A. Matarese" 2 => "B. Bellofiore" 3 => "P. Giacomelli" 4 => "G. Santoro" 5 => "N. Balato" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10096-008-0519-1" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Microbiol Infect Dis" "fecha" => "2008" "volumen" => "27" "paginaInicial" => "907" "paginaFinal" => "913" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18470544" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patients candidates for anti-tumour necrosis factor-alpha treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Sauzullo" 1 => "F. Mengoni" 2 => "R. Scrivo" 3 => "G. Valesini" 4 => "C. Potenza" 5 => "N. Skroza" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Int J Tuberc Lung Dis" "fecha" => "2010" "volumen" => "14" "paginaInicial" => "340" "paginaFinal" => "834" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Vassilopoulos" 1 => "S. Tsikrika" 2 => "C. Hatzara" 3 => "V. Podia" 4 => "A. Kandili" 5 => "N. Stamoulis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CVI.05299-11" "Revista" => array:6 [ "tituloSerie" => "Clin Vaccine Immunol" "fecha" => "2011" "volumen" => "18" "paginaInicial" => "2102" "paginaFinal" => "2108" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21994356" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-gamma release assay in patients considered for anti-tumor necrosis factor-alpha therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Casas" 1 => "A. Andreu" 2 => "X. Juanola" 3 => "X. Bordas" 4 => "F. Alcaide" 5 => "R. Moure" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.diagmicrobio.2010.12.020" "Revista" => array:7 [ "tituloSerie" => "Diagn Microbiol Infect Dis" "fecha" => "2011" "volumen" => "71" "paginaInicial" => "57" "paginaFinal" => "65" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21851871" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002939410004484" "estado" => "S300" "issn" => "00029394" ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Papay" 1 => "A. Eser" 2 => "S. Winkler" 3 => "S. Frantal" 4 => "C. Primas" 5 => "W. Miehsler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2362.2011.02502.x" "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Invest" "fecha" => "2011" "volumen" => "41" "paginaInicial" => "1071" "paginaFinal" => "1076" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21413978" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Garcovich" 1 => "A. Ruggeri" 2 => "M. D’Agostino" 3 => "F. Ardito" 4 => "C. De Simone" 5 => "G. Delogu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2011.04220.x" "Revista" => array:2 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2011" ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs tuberculin skin test" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Laffitte" 1 => "J.P. Janssens" 2 => "P. Roux-Lombard" 3 => "A.M. Thielen" 4 => "C. Barde" 5 => "G. Marazza" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2009.09331.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2009" "volumen" => "161" "paginaInicial" => "797" "paginaFinal" => "800" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19659473" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. De Andrade Lima" 1 => "M. De Andrade Lima" 2 => "V.M. De Lorena" 3 => "Y. De Miranda Gomes" 4 => "O. Lupi" 5 => "G. Benard" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2340/00015555-1151" "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2011" "volumen" => "91" "paginaInicial" => "694" "paginaFinal" => "697" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21629971" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical experience of QuantiFERON<span class="elsevierStyleSup">®</span>-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H.Y. Chiu" 1 => "P.R. Hsueh" 2 => "T.F. Tsai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2010.10137.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2011" "volumen" => "164" "paginaInicial" => "553" "paginaFinal" => "559" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21083541" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detection of IFN-gamma responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Latorre" 1 => "S. Mínguez" 2 => "M. Vilavella" 3 => "J. Díaz" 4 => "J.M. Carrascosa" 5 => "C. Prat" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2011" "editorial" => "European Respiratory Congress" "editorialLocalizacion" => "Amsterdam" ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Latorre" 1 => "M. De Souza-Galvao" 2 => "J. Ruiz-Manzano" 3 => "A. Lacoma" 4 => "C. Prat" 5 => "N. Altet" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00196608" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2010" "volumen" => "35" "paginaInicial" => "338" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20123845" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Goletti" 1 => "S. Carrara" 2 => "H. Mayanja-Kizza" 3 => "J. Baseke" 4 => "M.A. Mugerwa" 5 => "E. Girardi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2334-8-11" "Revista" => array:5 [ "tituloSerie" => "BMC Infect Dis" "fecha" => "2008" "volumen" => "8" "paginaInicial" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18226199" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "X.Q. Liu" 1 => "D.P. Dosanjh" 2 => "H. Varia" 3 => "K. Ewer" 4 => "P. Cockle" 5 => "G. Pasvol" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Infect Immun" "fecha" => "2004" "volumen" => "72" "paginaInicial" => "2574" "paginaFinal" => "2581" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15102765" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.A. Millington" 1 => "J.A. Innes" 2 => "S. Hackforth" 3 => "T.S. Hinks" 4 => "J.J. Deeks" 5 => "D.P. Dosanjh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "2007" "volumen" => "178" "paginaInicial" => "5217" "paginaFinal" => "5226" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17404305" "web" => "Medline" ] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Ruhwald" 1 => "T. Bodmer" 2 => "C. Maier" 3 => "M. Jepsen" 4 => "M.B. Haaland" 5 => "J. Eugen-Olsen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.00055508" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2008" "volumen" => "32" "paginaInicial" => "1607" "paginaFinal" => "1615" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18684849" "web" => "Medline" ] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0235" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Ruhwald" 1 => "J. Domínguez" 2 => "I. Latorre" 3 => "M. Losi" 4 => "L. Richeldi" 5 => "M.B. Pasticci" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Tuberculosis (Edinb)" "fecha" => "2011" "volumen" => "91" "paginaInicial" => "260" "paginaFinal" => "267" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010300000010/v1_201304241352/S157821901200306X/v1_201304241352/en/main.assets" "Apartado" => array:4 [ "identificador" => "6170" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Novelties in Dermatology" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010300000010/v1_201304241352/S157821901200306X/v1_201304241352/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901200306X?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 13 | 9 | 22 |
2024 Octubre | 75 | 52 | 127 |
2024 Septiembre | 93 | 52 | 145 |
2024 Agosto | 92 | 78 | 170 |
2024 Julio | 83 | 40 | 123 |
2024 Junio | 117 | 43 | 160 |
2024 Mayo | 84 | 36 | 120 |
2024 Abril | 82 | 39 | 121 |
2024 Marzo | 64 | 35 | 99 |
2024 Febrero | 76 | 33 | 109 |
2024 Enero | 50 | 34 | 84 |
2023 Diciembre | 69 | 25 | 94 |
2023 Noviembre | 76 | 35 | 111 |
2023 Octubre | 60 | 15 | 75 |
2023 Septiembre | 98 | 31 | 129 |
2023 Agosto | 61 | 18 | 79 |
2023 Julio | 65 | 40 | 105 |
2023 Junio | 70 | 30 | 100 |
2023 Mayo | 61 | 26 | 87 |
2023 Abril | 47 | 19 | 66 |
2023 Marzo | 62 | 21 | 83 |
2023 Febrero | 60 | 34 | 94 |
2023 Enero | 48 | 29 | 77 |
2022 Diciembre | 79 | 53 | 132 |
2022 Noviembre | 29 | 38 | 67 |
2022 Octubre | 23 | 25 | 48 |
2022 Septiembre | 27 | 27 | 54 |
2022 Agosto | 27 | 39 | 66 |
2022 Julio | 17 | 39 | 56 |
2022 Junio | 18 | 21 | 39 |
2022 Mayo | 43 | 50 | 93 |
2022 Abril | 48 | 41 | 89 |
2022 Marzo | 35 | 54 | 89 |
2022 Febrero | 38 | 32 | 70 |
2022 Enero | 28 | 45 | 73 |
2021 Diciembre | 26 | 49 | 75 |
2021 Noviembre | 46 | 42 | 88 |
2021 Octubre | 33 | 51 | 84 |
2021 Septiembre | 29 | 49 | 78 |
2021 Agosto | 34 | 35 | 69 |
2021 Julio | 23 | 37 | 60 |
2021 Junio | 36 | 36 | 72 |
2021 Mayo | 24 | 33 | 57 |
2021 Abril | 58 | 33 | 91 |
2021 Marzo | 48 | 36 | 84 |
2021 Febrero | 44 | 29 | 73 |
2021 Enero | 21 | 20 | 41 |
2020 Diciembre | 29 | 17 | 46 |
2020 Noviembre | 19 | 18 | 37 |
2020 Octubre | 13 | 9 | 22 |
2020 Septiembre | 32 | 20 | 52 |
2020 Agosto | 20 | 18 | 38 |
2020 Julio | 25 | 17 | 42 |
2020 Junio | 28 | 28 | 56 |
2020 Mayo | 20 | 15 | 35 |
2020 Abril | 42 | 17 | 59 |
2020 Marzo | 35 | 22 | 57 |
2020 Febrero | 4 | 0 | 4 |
2020 Enero | 4 | 0 | 4 |
2019 Diciembre | 10 | 4 | 14 |
2019 Noviembre | 6 | 2 | 8 |
2019 Septiembre | 10 | 0 | 10 |
2019 Agosto | 4 | 0 | 4 |
2019 Julio | 4 | 1 | 5 |
2019 Junio | 4 | 1 | 5 |
2019 Mayo | 7 | 13 | 20 |
2019 Abril | 2 | 8 | 10 |
2019 Marzo | 0 | 8 | 8 |
2019 Febrero | 4 | 0 | 4 |
2018 Diciembre | 7 | 0 | 7 |
2018 Noviembre | 1 | 0 | 1 |
2018 Septiembre | 7 | 0 | 7 |
2018 Agosto | 0 | 1 | 1 |
2018 Julio | 0 | 3 | 3 |
2018 Junio | 0 | 1 | 1 |
2018 Mayo | 0 | 6 | 6 |
2018 Abril | 0 | 4 | 4 |
2018 Marzo | 1 | 0 | 1 |
2018 Febrero | 40 | 5 | 45 |
2018 Enero | 38 | 7 | 45 |
2017 Diciembre | 77 | 12 | 89 |
2017 Noviembre | 51 | 8 | 59 |
2017 Octubre | 43 | 4 | 47 |
2017 Septiembre | 45 | 6 | 51 |
2017 Agosto | 61 | 9 | 70 |
2017 Julio | 62 | 23 | 85 |
2017 Junio | 74 | 19 | 93 |
2017 Mayo | 45 | 14 | 59 |
2017 Abril | 55 | 21 | 76 |
2017 Marzo | 60 | 25 | 85 |
2017 Febrero | 35 | 14 | 49 |
2017 Enero | 47 | 8 | 55 |
2016 Diciembre | 71 | 8 | 79 |
2016 Noviembre | 125 | 25 | 150 |
2016 Octubre | 126 | 24 | 150 |
2016 Septiembre | 224 | 18 | 242 |
2016 Agosto | 172 | 14 | 186 |
2016 Julio | 74 | 10 | 84 |
2016 Junio | 15 | 15 | 30 |
2016 Mayo | 6 | 25 | 31 |
2016 Abril | 7 | 1 | 8 |
2016 Marzo | 6 | 16 | 22 |
2016 Febrero | 10 | 9 | 19 |
2016 Enero | 10 | 8 | 18 |
2015 Diciembre | 5 | 11 | 16 |
2015 Noviembre | 43 | 10 | 53 |
2015 Octubre | 73 | 4 | 77 |
2015 Septiembre | 56 | 6 | 62 |
2015 Agosto | 22 | 8 | 30 |
2015 Julio | 183 | 8 | 191 |
2015 Junio | 115 | 9 | 124 |
2015 Mayo | 120 | 9 | 129 |
2015 Abril | 122 | 7 | 129 |
2015 Marzo | 105 | 9 | 114 |
2015 Febrero | 115 | 8 | 123 |
2015 Enero | 81 | 12 | 93 |
2014 Diciembre | 77 | 16 | 93 |
2014 Noviembre | 56 | 3 | 59 |
2014 Octubre | 69 | 3 | 72 |
2014 Septiembre | 44 | 1 | 45 |
2014 Agosto | 49 | 5 | 54 |
2014 Julio | 41 | 7 | 48 |
2014 Junio | 48 | 4 | 52 |
2014 Mayo | 59 | 8 | 67 |
2014 Abril | 30 | 3 | 33 |
2014 Marzo | 19 | 6 | 25 |
2014 Febrero | 29 | 12 | 41 |
2014 Enero | 24 | 4 | 28 |
2013 Diciembre | 21 | 9 | 30 |
2013 Noviembre | 18 | 5 | 23 |
2013 Octubre | 16 | 6 | 22 |
2013 Septiembre | 9 | 12 | 21 |
2013 Agosto | 8 | 18 | 26 |
2013 Julio | 10 | 15 | 25 |
2013 Junio | 11 | 13 | 24 |
2013 Mayo | 11 | 21 | 32 |
2013 Abril | 15 | 18 | 33 |
2013 Marzo | 13 | 16 | 29 |
2013 Febrero | 44 | 6 | 50 |
2013 Enero | 58 | 16 | 74 |
2012 Diciembre | 61 | 13 | 74 |